In vitro inhibition of human cytomegalovirus replication by desferrioxamine-Reference-Cited by-同舟云学术

In vitro inhibition of human cytomegalovirus replication by desferrioxamine

Published:1994-09 Issue:1 Volume:25 Page:73-77
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Cinatl J.,Cinatl J.,Rabenau H.,Gümbel H.O.,Kornhuber B.,Doerr H.W.

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference21 articles.

1. Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with haemochromatosis;Allain;Br. J. Clin. Pharmac.,1987

2. Ribonucleotide reductase induced by herpes simplex type 1 virus: characterization of a distinct enzyme;Averett;J. Biol. Chem.,1983

3. Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1;Averett;J. Virol.,1984

4. Impairment of nucleotide metabolism by iron chelating deferoxamine;Barankiewicz;Biochem. Pharmacol.,1987

5. Metabolic activation of the nucleoside analog 9-(1,3-dihydroxy-2-propoxymethyl)guanine in human diploid fibroblasts infected with human cytomegalovirus;Biron,1985

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Immune-Specific E3 Ubiquitin Ligase MARCH1 Is Upregulated during Human Cytomegalovirus Infection to Regulate Iron Levels;Journal of Virology;2022-03-23

2. Tocilizumab Treatment Effect on Iron Homeostasis in Severe COVID-19 Patients;Acta Haematologica;2022

3. OUTBREAK of novel corona virus disease (COVID-19): Antecedence and aftermath;European Journal of Pharmacology;2020-10

4. The role of iron in viral infections;Frontiers in Bioscience;2020

5. The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation;Cells;2019-12-20